Evidence map›Paper›PMID 24802758›Full record

ArticleThe Journal of biological chemistry2014

A cryptic polyreactive antibody recognizes distinct clades of HIV-1 glycoprotein 120 by an identical binding mechanism.

Jordan D Dimitrov, Cyril Planchais, Tobias Scheel, Delphine Ohayon, Stephane Mesnage, Claudia Berek, Srinivas V Kaveri, Sébastien Lacroix-Desmazes

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Jordan D DimitrovFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Unité Mixte de Recherche S 1138, 75006 Paris, France, the Université Paris Descartes, Unité Mixte de Recherche S 1138, Paris, France, INSERM U1138, 75006 Paris, France, jordan.dimitrov@crc.jussieu.fr.
Cyril PlanchaisFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Unité Mixte de Recherche S 1138, 75006 Paris, France, the Université Paris Descartes, Unité Mixte de Recherche S 1138, Paris, France, INSERM U1138, 75006 Paris, France.
Tobias Scheelthe Deutsches Rheuma-Forschungszentrum, Institut der Leibniz-Gemeinschaft, 13092 Berlin, Germany, and.
Delphine OhayonFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Unité Mixte de Recherche S 1138, 75006 Paris, France, the Université Paris Descartes, Unité Mixte de Recherche S 1138, Paris, France, INSERM U1138, 75006 Paris, France.
Stephane Mesnagethe Krebs Institute, University of Sheffield, Firth Court, Western Bank, Sheffield S10 2TN, United Kingdom.
Claudia Berekthe Deutsches Rheuma-Forschungszentrum, Institut der Leibniz-Gemeinschaft, 13092 Berlin, Germany, and.
Srinivas V KaveriFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Unité Mixte de Recherche S 1138, 75006 Paris, France, the Université Paris Descartes, Unité Mixte de Recherche S 1138, Paris, France, INSERM U1138, 75006 Paris, France.
Sébastien Lacroix-DesmazesFrom the Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Unité Mixte de Recherche S 1138, 75006 Paris, France, the Université Paris Descartes, Unité Mixte de Recherche S 1138, Paris, France, INSERM U1138, 75006 Paris, France.
Délégation Paris 5 · FRLeibniz Association · DEUniversité Paris Cité · FRSorbonne Université · FRUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyreactive antibodies play an important role for neutralization of human immunodeficiency virus (HIV). In addition to intrinsic polyreactive antibodies, the immune system of healthy individuals contains antibodies with cryptic polyreactivity. These antibodies acquire promiscuous antigen binding potential post-translationally, after exposure to various redox-active substances such as reactive oxygen species, iron ions, and heme. Here, we characterized the interaction of a prototypic human antibody that acquires binding potential to glycoprotein (gp) 120 after exposure to heme. The kinetic and thermodynamic analyses of interaction of the polyreactive antibody with distinct clades of gp120 demonstrated that the antigen-binding promiscuity of the antibody compensates for the molecular heterogeneity of the target antigen. Thus, the polyreactive antibody recognized divergent gp120 clades with similar values of the binding kinetics and quantitatively identical changes in the activation thermodynamic parameters. Moreover, this antibody utilized the same type of noncovalent forces for formation of complexes with gp120. In contrast, HIV-1-neutralizing antibodies isolated from HIV-1-infected individuals, F425 B4a1 and b12, demonstrated different binding behavior upon interaction with distinct variants of gp120. This study contributes to a better understanding of the physiological role and binding mechanism of antibodies with cryptic polyreactivity. Moreover, this study might be of relevance for understanding the basic aspects of HIV-1 interaction with human antibodies.

Indexed as

Antibodies, MonoclonalAntibodies, NeutralizingBinding Sites, AntibodyHIV-1HIV AntibodiesHIV Envelope Protein gp120HIV InfectionsHumansKineticsThermodynamicsAntibodies, MonoclonalAntibodies, Neutralizinggp120 protein, Human immunodeficiency virus 1HIV AntibodiesHIV Envelope Protein gp120AntibodyAntibody Polyreactivitygp120HemeHIV-1 ProteaseProtein-Protein InteractionThermodynamics

Identifiers

PMID24802758
PMCPMC4067210
OpenAlexW2084880363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.